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NETosis, an antimicrobial form of neutrophil cell death, is considered a primary source 
of citrullinated autoantigens in rheumatoid arthritis (RA) and immunogenic DNA in sys-
temic lupus erythematosus (SLE). Activation of the citrullinating enzyme peptidylarginine 
deiminase type 4 (PAD4) is believed to be essential for neutrophil extracellular trap (NET) 
formation and NETosis. PAD4 is therefore viewed as a promising therapeutic target to 
inhibit the formation of NETs in both diseases. In this review, we examine the evidence for 
PAD4 activation during NETosis and provide experimental data to suggest that protein 
citrullination is not a universal feature of NETs. We delineate two distinct biological pro-
cesses, leukotoxic hypercitrullination (LTH) and defective mitophagy, which have been 
erroneously classified as “NETosis.” While these NETosis mimics share morphological 
similarities with NETosis (i.e., extracellular DNA release), they are biologically distinct. 
As such, these processes can be readily classified by their stimuli, activation of distinct 
biochemical pathways, the presence of hypercitrullination, and antimicrobial effector 
function. NETosis is an antimicrobial form of cell death that is NADPH oxidase-dependent 
and not associated with hypercitrullination. In contrast, LTH is NADPH oxidase-indepen-
dent and not bactericidal. Rather, LTH represents a bacterial strategy to achieve immune 
evasion. It is triggered by pore-forming pathways and equivalent signals that cumulate 
in calcium-dependent hyperactivation of PADs, protein hypercitrullination, and neutrophil 
death. The generation of citrullinated autoantigens in RA is likely driven by LTH, but 
not NETosis. Mitochondrial DNA (mtDNA) expulsion, the result of a constitutive defect 
in mitophagy, represents a second NETosis mimic. In the presence of interferon-α and 
immune complexes, this process can generate highly interferogenic oxidized mtDNA, 
which has previously been mistaken for NETosis in SLE. Distinguishing NETosis from LTH 
and defective mitophagy is paramount to understanding the role of neutrophil damage in 
immunity and the pathogenesis of human diseases. This provides a framework to design 
specific inhibitors of these distinct biological processes in human disease.
Keywords: netosis, leukotoxic hypercitrullination, citrullination, rheumatoid arthritis, systemic lupus 
erythematosus, nadpH oxidase, peptidylarginine deiminase, mitophagy
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introdUCtion
the History of nets: discovery and 
Misconceptions
Following Elias Metchnikoff ’s initial proposal that wandering 
cells (“Wanderzellen”), known today as neutrophils, phagocytose 
and kill bacteria (1), it took an additional 117 years to elucidate 
a second mechanism by which neutrophils can entrap microbial 
agents (2). In 2004, Brinkmann and colleagues reported that 
neutrophils can release nuclear chromatin together with granule 
proteins to form an extracellular mesh that binds and kills bacteria 
while also degrading virulence factors (2). The term neutrophil 
extracellular traps (NETs) was introduced to describe these 
neutrophil-derived antimicrobial fibers (2). Since the extracel-
lular release of chromatin has historically been linked to necrosis 
(3), these initial findings allowed for speculation as to whether 
NETs were released from necrotic cells or as an active function of 
live neutrophils (4). It was later shown that NETs are released as 
a consequence of a regulated form of cell death called NETosis, 
which is dependent on the generation of reactive oxygen species 
(ROS) by NADPH oxidase (5, 6). To date, NETs and NETosis are 
used synonymously.
The discovery of NETs has generated an avalanche of research 
over the past 10 years, providing important insights into novel 
antimicrobial pathways and a plethora of pathologies as diverse as 
sepsis and thrombosis, autoimmune and metabolic diseases, and 
immunodeficiency and cancer. At the same time, the definition 
of NETosis has evolved rapidly, suffering many modifications that 
allowed researchers to incorporate and potentially misclassify 
almost any biological process involving the extrusion of neutro-
phil DNA (nuclear or mitochondrial) (7). The term “extracellular 
trap” has moreover been applied to an increasing number of cell 
types that release chromatin (e.g., eosinophils, mast cells, and 
macrophages) (8).
While the initiation and execution components during 
NETosis are not yet fully understood, unique cellular changes 
and biochemical pathways that distinguish NETosis from other 
forms of cell death have been well characterized (5, 9–11). Despite 
this, the definition of NETs/NETosis still hinges on purely mor-
phological descriptors, primarily the extrusion of DNA. This 
arguably broad definition has generated an ever-increasing list 
of stimuli and pathways reported to induce NETs, while NETosis 
has inevitably become an umbrella term that encompasses a 
diverse group of cellular processes with potentially fundamental 
differences in biology and significance for immunity and disease. 
While some NETs are part of a unique form of programed cell 
death that evolved to fight pathogens (referred to in this review as 
NETosis), it is conceivable that many processes currently identi-
fied as “NETosis” may be the consequence of cellular damage 
or other forms of cell death (12). Distinguishing these different 
forms of NETs has critical implications. If NETs are driven by 
different biological processes, it is unlikely that all forms of DNA 
extrusion will have the same capacity to fight infection, drive 
various human diseases, or be inhibited by targeting a single 
biochemical pathway.
Our interest in NETs is related to the process of protein citrul-
lination. To date, it is commonly accepted that citrullination of 
histones by peptidylarginine deiminase type 4 (PAD4) is required 
for chromatin unfolding and the formation of NETs (13). This 
misconception has drawn attention to PAD4 as a promising cel-
lular target to broadly inhibit NETosis (14). Additionally, this has 
led to the proposal that this form of neutrophil death represents 
a major source of citrullinated autoantigens in rheumatoid 
arthritis (RA) (15, 16), an autoimmune disease characterized by 
the appearance of anti-citrullinated protein antibodies (ACPAs) 
(17). Similarly, it has focused interest on PAD4 as a therapeutic 
target in systemic lupus erythematosus (SLE) in which NETosis 
is believed to play a pathogenic role (18).
In this review, we will revisit some aspects of citrullination dur-
ing the process of “NETosis” that we consider controversial. We 
provide experimental evidence to highlight differences in protein 
citrullination induced by various NET-inducing stimuli and pro-
pose a framework to understand these disparities. The corollary 
of this work is that protein citrullination can distinguish at least 
two mutually exclusive mechanisms that generate extracellular 
DNA structures. One of these is NETosis, an antimicrobial pro-
cess that is not associated with cellular hypercitrullination. The 
second mechanism, which merely mimics NETosis, is induced by 
calcium ionophores or membranolytic agents that cause calcium-
dependent hyperactivation of PADs, cellular hypercitrullination, 
and as a consequence extrusion of DNA. This mechanism, which 
we call leukotoxic hypercitrullination (LTH), is not antimicrobial, 
but linked to the production of citrullinated antigens in RA. 
Moreover, it is utilized by some pathogenic bacteria to abrogate 
neutrophil activity. A third process that can readily be confused 
with NETosis is the extracellular release of mitochondrial DNA 
(mtDNA), which results from a constitutive defect in mitophagy 
in neutrophils (19). This process has not been associated with 
protein citrullination. However, it is linked to the production 
of extracellular oxidized mtDNA (ox-mtDNA), which is highly 
interferogenic and initially confounded with NETosis in SLE (19). 
The need for a biochemical definition of NETs and their distinc-
tion from other mechanisms of neutrophil damage based on their 
antimicrobial and pathogenic effects will be discussed.
nets released during antimicrobial 
programed Cell death (netosis)
The capacity of neutrophils to die by ROS-dependent “autotoxic-
ity” in response to phorbol myristate acetate (PMA), a cocar-
cinogen derived from oil of the Croton shrub (20), was initially 
described by Min-Fu Tsan in 1980 (21). It was later appreciated 
that this form of neutrophil death differs from apoptosis and 
necrosis. Early changes in nuclear morphology, specifically 
chromatin decondensation and rupture of the nuclear envelope, 
are followed by rupture of the plasma membrane and subse-
quent dispersal of cytoplasmic contents into the extracellular 
space (22). The significance of this novel form of cell death was 
not recognized until 2004, when Brinkmann and colleagues 
reported two major findings (2). First, they found that the mate-
rial released from the dying neutrophils was chromatin coated 
with granular antimicrobial proteins, forming extracellular fib-
ers with bacterial binding capacity (NETs). Second, they noted 
that these fibers have the capacity to degrade virulence factors 
and kill bacteria, suggesting a novel mechanism by which the 
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innate immune system can limit acute infections. Importantly, 
the production of NETs was reproduced with two physiological 
stimuli: interleukin-8 (IL-8) and lipopolysaccharide (LPS). The 
existence of NETs in vivo was confirmed in both experimental 
dysentery and spontaneous human appendicitis (2). These 
studies thus provided evidence that NETs may not simply be an 
artifact of PMA toxicity, but rather a process of potential physi-
ological relevance.
Several features initially suggested that NETs were actively 
generated by neutrophils and not just a consequence of cellu-
lar rupture resulting from known forms of cell death (2). The 
concept that live neutrophils can actively weave extracellular 
traps using their own DNA created substantial excitement about 
this novel antibacterial process. Yet, in the absence of molecular 
mechanism, the argument that NETs were merely an artifact of 
necrosis remained (4). Subsequent studies demonstrated that 
NETs indeed emerge from dying neutrophils (5), but this process 
was neither related to neutrophil apoptosis nor necrosis. Instead, 
it was shown that PMA induces NETs through the unique form 
of cell death that was dependent on ROS production by NADPH 
oxidase (5, 21, 22). Acknowledging the non-accidental nature 
of committed cell death by NET formation distinct of necrosis, 
this process was named NETosis (in analogy to other forms of 
programed cell death) (6). Parallel studies demonstrated that 
Staphylococcus aureus (S. aureus) is able to replicate the changes 
in neutrophil morphology seen with PMA, supporting the 
biological relevance of this process as an antibacterial strategy. 
However, bacterial growth conditions that avoided expression 
of staphylococcal toxins (toxin-free S. aureus) were required 
to reproduce NETosis (5). The significance of using toxin-free, 
rather than virulent bacteria in these experiments will be dis-
cussed later.
Morphological and Biochemical Features 
that define netosis
Neutrophil extracellular traps induced by PMA or “toxin-free” 
S. aureus exhibit unique features that support NETosis as a 
novel, regulated form of cell death (5). Morphologically, NETosis 
begins with the disappearance of nuclear lobules. This is followed 
by chromatin decondensation and disintegration of the nuclear 
envelope into small vesicles containing this decondensed chro-
matin. Subsequently, the membranes of these nuclear vesicles 
and cytoplasmic granules disintegrate, allowing for mixing of 
chromatin with cytoplasmic and granule contents. Finally, the 
plasma membrane ruptures and allows for the release of chro-
matin decorated with antimicrobial granule proteins into the 
extracellular space (the NET). While this process is distinct from 
necrosis and apoptosis (5), it is still uncertain whether NETosis 
may be mechanistically associated with other forms of regulated 
cell death (e.g., autophagy and necroptosis) (12, 23–27).
The production of ROS by NADPH oxidase is considered the 
biochemical hallmark in the process of NETosis (5). Much of 
the current understanding of the molecular mechanisms driving 
NETosis is based on studies using PMA, a phorbol ester that 
mimics diacylglycerol (20, 28). PMA directly activates protein 
kinase C (PKC) (28), which then phosphorylates the p40phox 
and p47phox components of NADPH oxidase. This induces the 
production of superoxide (29–31). Several kinases have been 
implicated downstream of PKC, including c-Raf, MEK, Akt, 
and ERK (11, 32–34). However, the mechanistic role of these 
enzymes is not well understood. For example, ERK has been 
proposed as a major downstream kinase involved in NETosis via 
phosphorylation of p47phox and activation of NADPH oxidase 
(11). However, conflicting evidence exists as to whether ERK is 
indeed activated upstream or downstream of ROS production 
(11, 34). Nevertheless, an additional contribution of ERK to this 
process may not be required as PKC can directly activate NADPH 
oxidase (29–31).
Not every neutrophil undergoes NETosis upon activation with 
PMA. The mechanism behind why some cells survive and others 
die remains unclear. In cells that commit to NETosis, oxidative 
burst triggers the dissociation and activation of neutrophil 
elastase (NE) from a membrane-associated complex called the 
“azurosome” in a myeloperoxidase (MPO)-dependent process 
(35). Once in the cytoplasm, NE first cleaves F-actin and subse-
quently translocates to the nucleus. Here, NE degrades histones, 
thereby promoting chromatin decondensation (9, 10, 35). The 
degradation and disassembly of the actin cytoskeleton may 
further facilitate the disruption of the cytoplasmic membrane, 
a requirement for NET release (35). Citrullination of histones, 
along with their proteolytic cleavage, is considered essential for 
the disassembly of chromatin and release of DNA during NETosis 
(36, 37). Evidence for the presumed citrullination of histones dur-
ing NETosis is reviewed in the next sections.
pad activation and Cellular 
Hypercitrullination in neutrophils
Citrulline is a non-essential amino acid that is generated in 
proteins by posttranslational enzymatic conversion of arginine 
residues to peptidylcitrulline. This modification, called either 
deimination or citrullination, is catalyzed by the PADs, a family 
of calcium-dependent enzymes (38–40). Among the five PAD 
enzymes encoded in humans (PAD1–PAD4 and PAD6) (41–45), 
PAD4 has received special attention in neutrophil biology. This 
enzyme, initially named PAD5 (PAD V), was cloned from a 
human myeloid leukemia cell line (HL-60 cells) induced to dif-
ferentiate into granulocytes (44). Expression of PAD4 was later 
found in both human eosinophils and neutrophils (46). PAD4 
shows nuclear localization, and histones were among the first 
PAD4 substrates to be identified (47, 48). To date, more than 
70 putative PAD4 substrates have been described (49, 50). It 
was initially proposed that this enzyme may act as a transcrip-
tional regulator by modifying the function of histones (51, 52), 
but PAD4-deficient mice demonstrated normal development, 
suggesting that, at least in mice, PAD4 has no essential role in 
steady-state neutrophil functions or development (37).
The mechanisms controlling PAD activation in cells are not yet 
fully understood. Since PADs are calcium-dependent enzymes 
(38), stimuli that potently increase intracellular calcium con-
centration have been used to identify cellular targets of protein 
citrullination in cells (48, 49, 53, 54). Ionophores are compounds 
that form lipid-soluble complexes with polar cations and act as 
vehicles in the transport of ions across biological membranes 
(55). A23187 (calcimycin) and ionomycin, both derived from 
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FigUre 1 | Calcium ionophores induce cellular hypercitrullination in 
neutrophils. After informed consent, peripheral blood neutrophils were 
isolated from healthy donors as previously described (58), resuspended in 
HBSS/10 mM Hepes/1.5 mM CaCl2, and incubated with 1 μM ionomycin or 
5 μM A23187 at 37°C for 30–180 min. Neutrophils incubated for 3 h in the 
absence of stimulus were used as negative control. General protein 
citrullination was visualized by anti-modified citrulline (AMC) immunoblotting 
(59) (upper panel) and histone H3 citrullination (Cit-H3) using antibodies 
against citrullinated histone H3 (citrulline 2 + 8 + 17) (Abcam, Cat# ab5103) 
(middle panel). Histone H3 (H3) was detected as loading control (lower panel) 
(anti-histone H3, Abcam, Cat# ab1791). The experiments were performed on 
at least three separate occasions with similar results.
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Streptomyces species (55–57), are divalent carboxylic ionophores 
with selectivity for calcium (calcium ionophores). Induction of 
calcium influx by either A23187 or ionomycin in neutrophils 
results in hyperactivation of PADs and citrullination of a myriad 
of proteins across all molecular weights (48, 54), which we termed 
cellular hypercitrullination (58). During this process, citrul-
linated proteins accumulate with time and plateau ~3 h after cell 
activation (Figure 1).
Citrullination results in a loss of positive charge per modified 
arginine residue, thus reducing the net charge of the modified 
protein and increasing its hydrophobicity. This can lead to 
protein unfolding and either gain or more likely loss of protein 
function (51, 52, 60–62). While the spectrum of citrullinated 
proteins (i.e., the citrullinome) generated by calcium ionophores 
in neutrophils has not been fully characterized, known targets 
include nuclear proteins (nucleophosmin and histones) (48), 
antimicrobial proteins (MPO, NE, azurocidin, and defensins) 
(63), and components of the cytoskeleton (vimentin and actin) 
(54, 64). Among these substrates, citrullination of histones and 
vimentin promote chromatin decondensation and the disas-
sembly of intermediate filaments, respectively (36, 61). The effect 
of hypercitrullination on other cellular proteins is unknown, but 
the vast accumulation of citrullination-induced protein unfold-
ing is likely to provoke functional and structural collapse of the 
cell. For example, overexpression and spontaneous activation of 
PAD4 in osteosarcoma U2OS cells, without any other element 
required for NETosis (i.e., NE or MPO), is sufficient to induce 
cell disintegration and the production of NET-like structures 
(pseudo-NETosis) (65). This may also explain how neutrophils 
become dismantled and release their intracellular contents upon 
hyperactivation of PAD4 with calcium ionophores, including the 
release of genomic DNA (gDNA) that mimics NET formation 
(36). Although the mechanisms that drive cell damage and DNA 
extrusion by calcium ionophores are biochemically distinct from 
NETosis, as described in detail below (66), both PMA and calcium 
ionophores have been equivalently used to study this unique form 
of neutrophil cell death.
the Misconception that pad4 is required 
for netosis
The Race to Find Mechanisms of Chromatin 
Decondensation during NETosis
While early studies demonstrated that ROS production by 
NADPH oxidase was required to initiate NET formation (5), the 
discovery of a downstream molecular mechanism driving chro-
matin decondensation during NETosis, specifically the cleavage 
of histones by NE, lagged behind (10, 35). During this time, it 
was found that (1) hypercitrullination of histones by PAD4 pro-
motes chromatin unfolding and (2) calcium ionophores, potent 
activators of PADs, induce extracellular release of DNA similar 
to NETosis (36). Assuming that the nature of NETs generated by 
calcium ionophores and PMA were the same, PAD4 activation 
and histone citrullination were proposed to be the missing link 
between ROS production and chromatin decondensation during 
NETosis (13, 36). In fact, the belief that PAD4 is activated by ROS 
during NETosis prevails to this day (67), although evidence to 
support this concept is lacking. Since a reducing environment is 
necessary to maintain the active site free thiol Cys645 required for 
PAD4 function (68, 69), we can anticipate that oxidation of PAD4 
by ROS will instead inactivate the enzyme.
While a lack of biochemical insight initially suggested that NETs 
induced by calcium ionophores and PMA were identical, subse-
quent studies established that they are the consequence of bio-
logically distinct processes. The formation of NET-like structures 
induced by calcium ionophores occurs more rapidly than those 
formed during NETosis. Additionally, this process is independent 
of ERK and NADPH oxidase activity (a hallmark of NETosis), 
and thus often referred to as NADPH oxidase-independent NET 
formation (32, 66). These calcium ionophore-induced structures 
are in part mediated by calcium-activated small conductance 
potassium (SK) channel member SK3 and mitochondrial ROS 
(mtROS) (32), and completely dependent on calcium influx, 
unlike those formed during PMA-induced NETosis (32, 66). No 
evidence exists indicating that NE is required for the induction 
of “NETs” or citrullination by calcium ionophores (70), nor 
that F-actin and/or histones are cleaved during this process, as 
required during NETosis (10, 35). Notably, the calcium require-
ment for calcium ionophore-induced “NET” formation is not 
surprising as PAD activation and cellular hypercitrullination are 
calcium-dependent processes. In contrast to calcium ionophores, 
however, NETosis induced by PMA proceeds without PAD4 
activation and histone citrullination (32, 71). Moreover, PMA is 
not only unable to initiate protein citrullination in neutrophils 
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FigUre 2 | Calcium ionophores and the pore-forming toxin pVL from 
S. aureus, but not netosis-inducing stimuli, activate cellular 
hypercitrullination in neutrophils. Purified human neutrophils in 
HBSS/10 mM Hepes/1.5 mM CaCl2 were incubated (a) in the absence or 
presence of 100 nM PMA, 500 ng/mL LPS, 1 μM ionomycin, or 5 μM 
A23187 at 37°C for 3 h, or (B) in the absence or presence of PLV from 
S. aureus (recombinant LukS and LukF from IBT BioServices) at 30 or 
100 nM for 90 min at 37°C. Total citrullinated proteins (AMC), citrullinated 
histone H3 (citH3), and histone H3 (H3) (loading control) were detected by 
immunoblotting. The experiments were performed on at least two separate 
occasions with similar results.
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(Figure 2A), but also acts as a potent inhibitor of PAD4 in these 
cells (71). As such, PAD4 hyperactivation induced with calcium 
ionophores is significantly inhibited by PMA in a process that is 
dependent on PKCα (71). While the mechanism by which this 
kinase suppresses the activity of PAD4 is not elucidated, it is 
interesting that a different PKC isoform (i.e., PKCζ) is required 
for PAD4 activation induced by calcium ionophores (71). This 
suggests that PAD4 is regulated via phosphorylation. By activat-
ing different kinases, PAD4 function may be stimulus dependent, 
thus avoiding unwanted effects of protein citrullination during 
NETosis and other biologically relevant processes.
Two major conclusions can be drawn from these data. First, 
calcium ionophores can induce cellular hypercitrullination 
and NET-like structures, but this process is not associated with 
NETosis (i.e., an antimicrobial form of cell death dependent 
on NADPH oxidase) (5). Second, NETosis is associated with a 
decrease in PAD4 activity and absence of cellular hypercitrulli-
nation (Figure 2A). Regrettably, the original misconception that 
hypercitrullination occurs during NETosis remains to date.
The Erroneous Use of Citrullinated Histones as 
Specific Markers of NETosis
The identification of biochemical markers associated with spe-
cific forms of cell death is critical to study their mechanisms and 
biological relevance both in vitro and in vivo (23). Different to 
other forms of programed cell death, unique markers of NETosis 
have not yet been identified. Although cellular hypercitrullination 
induced by calcium ionophores targets a broad range of proteins 
(48, 54), initial studies using these ionophores to suggest a role 
of citrullination during NETosis focused entirely on the analysis 
of histones (36). This erroneously created the idea that histones 
were the only targets of ionophore-induced citrullination in 
neutrophils, and that histone citrullination was the mechanism 
underlying dismantling of the cell in response to calcium influx. 
Not only did the misconception that calcium ionophores induce 
NETosis become accepted, but it also fueled dogmatic belief that 
histone citrullination can serve as a specific biomarker for this 
form of cell death. Given that PAD4 is actively inhibited during 
NETosis (71), the detection of citrullinated histones both in vitro 
and in vivo can be explained by other means.
First, PAD4 targets histones as a mechanism to regulate 
transcription upon cell activation (72–74). The detection of 
citrullinated histones alone in  vivo may thus identify activated 
cells, rather than cells dying by NETosis (75). Second, histone 
citrullination is similarly observed in other forms of cell death 
such as apoptosis (58, 76), while shown to be inhibited during 
NETosis (71). Identifying extracellular citrullinated histones 
together with other neutrophil contents (DNA, MPO, PR3, and 
elastase, among others) is therefore not a suitable indicator of 
NETosis, but may rather indicate that neutrophils are dying by 
a form of cell death that is distinct from NETosis. Third, promi-
nent citrullination of histones and extracellular release of DNA 
are rapidly induced as consequence of membranolytic damage 
of neutrophils (i.e., LTH). This distinct form of death can easily 
be confused with NETosis, as discussed in detail below. Finally, 
isolated neutrophils, in the absence of NETosis-inducing stimuli, 
show increased staining for citrullinated histones over time. This 
may represent spontaneous cell death by apoptosis or evolving 
activation/damage suffered during neutrophil purification. In the 
absence of appropriate negative controls, any stimulus, includ-
ing PMA, will thus appear to induce neutrophil citrullination. 
Importantly, the use of PAD4-deficient cells or PAD inhibitors is 
not suitable negative controls to discard spontaneous activation 
of PAD4. In the opinion of these authors, a large number of stud-
ies that have reported citrullination in the setting of NETosis lack 
appropriate controls to delineate whether citrullination is induced 
upon stimulation or merely represents background staining. The 
absence of negative controls may thus explain why an unlikely 
number of stimuli tested have been shown to induce some degree 
of citrullination in neutrophils, and why the reproducibility of 
these findings remains poor.
The Haste of Linking NETosis and Citrullination
The excitement and expectations regarding citrullination and 
NETosis for systemic autoimmunity, the arbitrary use of PMA 
and calcium ionophores to induce NETs, and some overzeal-
ous data interpretation may have also contributed to keep the 
erroneous concepts about hypercitrullination in NETosis alive. 
For example, in a frequently cited review on PAD4 and NET 
formation (13), 16 references were included to establish that 
PMA induces PAD4 activation during NETosis. This includes 
the original paper by Brinkmann and colleagues, which was 
published 5 years prior to data suggesting that PAD4 is involved 
in NET formation (2, 9, 10, 27, 37, 77–87). In fact, only 1 
6Konig and Andrade NETosis and NETosis-Mimics
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of these 16 references included experiments involving protein 
citrullination. The majority of the referenced studies merely 
noted the presence of histones in NETs, and not histone citrul-
lination in NETs.
The misconception that PMA induces hypercitrullination and 
that calcium ionophores drive NETosis is more than a semantic 
problem. For example, in a recent study, NETs induced with PMA 
were used to demonstrate that monoclonal antibodies generated 
from RA synovial B cells target citrullinated histones in NETs 
(88). Considering that PMA effectively blocks citrullination (71), 
it is much more likely that cross-reactivity of RA autoantibodies 
with native (uncitrullinated) histones or other NET components 
explains these findings. Nevertheless, the study embraced the 
misconception that NETosis is a source of citrullinated autoanti-
gens in RA. Similarly, calcium ionophores are potent inducers of 
neutrophil hypercitrullination and citrullinated RA autoantigens 
(54, 63), which may be erroneously interpreted as the result of 
NETosis. In this context, the premature excitement and hastiness 
surrounding the rapidly growing field of NETosis has already 
misguided our understanding of etiology and pathogenesis of 
human diseases.
The Incomplete Understanding of the Role of PAD4 
in the Immune System
Peptidylarginine deiminase type 4 plays a major role in epigenetic 
regulation via the citrullination of histones and transcription 
factors (72–74, 89–95). In the immune system, PAD4 promotes 
cytokine production by augmenting chromatin association of 
E2F-1 and decreasing HP1-mediated transcriptional repression 
of cytokine genes (74, 89). Moreover, PAD4 inhibitors were 
shown to decrease pro-inflammatory Th1 and Th17 responses 
and to increase anti-inflammatory Th2 responses both in  vitro 
and in  vivo (96). PAD inhibition also blocks the functional 
maturation of dendritic cells induced by toll-like receptor ago-
nists (97). Despite this multifaceted role of PAD4 for immune 
function, the prominent misconception that PAD4 is required 
for NETosis has frequently led investigators to postulate that the 
anti-inflammatory effects of PAD inhibitors seen in vivo are best 
explained by blocking NET formation. Regardless of whether 
NETosis may have any role in disease pathogenesis, the observed 
benefit of PAD inhibition in experimental models of inflamma-
tion and autoimmunity is thus haphazardly attributed to limiting 
NET formation. This has importantly led to the current paradigm 
that NETs are pathogenic in vivo, confounding our understand-
ing of disease pathogenesis.
For example, inhibition of NETosis by propylthiouracil (PTU) 
induces the production of anti-MPO antibodies and vasculitis 
in rats (98), suggesting that the normal process of NETosis 
is protective against this autoimmune process. However, the 
finding that PAD inhibition by Cl-amidine decreases PTU-
induced autoantibody production in this model has been 
paradoxically interpreted as evidence that excessive formation 
of NETs is implicated in the production of these antibodies 
and vasculitis (75). The possibility that PAD inhibition may 
act through mechanisms different from NETosis was not con-
sidered. In the case of SLE, cumulative evidence now suggests 
that NETosis is not involved in the disease pathogenesis, as 
discussed below (19, 99, 100). Thus, the demonstrated benefits 
of PAD inhibition in experimental models of lupus, attributed 
to a decreased burden of NETosis (18, 101), may indeed be 
mediated by alternative mechanisms, such as the transcriptional 
regulation of anti-inflammatory pathways by these inhibitors. 
The inhibition of PAD4 activity as direct evidence in vivo that 
citrullination and NETosis are linked to disease pathogenesis 
therefore requires critical evaluation.
pMa-induced netosis vs. nets induced 
by Calcium ionophores: Biological 
relevance and proposed physiological 
Counterparts
Phorbol myristate acetate and calcium ionophores have had a 
historical role in the functional understanding of the immune 
system. Since the early 1970s, these molecules have been used 
as surrogate stimuli that mimic signals induced by microbial 
and immune products, simplifying the study of mechanisms 
and pathways of immune activation (102, 103). In neutrophils, 
PMA potently activates ROS production via NADPH oxidase 
and induces degranulation (104–109). PMA has no effect on 
intracellular calcium during neutrophil activation (110, 111). 
This may also explain the inability of PMA to activate PAD4, in 
addition to the inhibition mediated by PKCα (71). In contrast, 
calcium ionophores have been used to study the role of calcium 
in neutrophil function (109, 112–114). While calcium iono-
phores also induce neutrophil degranulation (109, 114), these 
molecules are extremely weak stimulators of NADPH oxidase 
activity as compared to PMA (110, 115). Because of their func-
tional divergence, PMA and calcium ionophores are commonly 
used in combination to achieve maximal activation of cellular 
responses that require elevated intracellular calcium and PKC 
activation (116, 117).
Although a large number of stimuli with potential biological 
relevance have been proposed to induce NETosis (13, 118), 
the underlying mechanisms for the majority of these stimuli 
have not been elucidated. Instead, studies have focused on 
understanding the pathways used by PMA and calcium 
ionophores to induce NETs, assuming that these surrogates 
are analogous to NETosis in  vivo. The biochemical pathways 
activated by immune and microbial stimuli, however, may 
not completely replicate those induced by PMA or calcium 
ionophores. Stimuli such as IL-8 and LPS, initially used to 
demonstrate that NETs are not simply an artifact of PMA treat-
ment, are neither efficient in driving ROS production (as seen 
with PMA) nor in increasing intracellular calcium (analogous 
to calcium ionophores) (119–123). The precise mechanism of 
NET induction with both IL-8 and LPS is unknown, and their 
ability to reliably reproduce NETosis is questionable (27, 124). 
Other soluble factors, such as tumor necrosis factor-α (TNF-α) 
(37, 79), have similar limitations in explaining the induction 
of NETs (125).
The potential importance of NETs in human biology is 
supported by the direct induction of NETosis by pathogens. 
The fungi Candida albicans (C. albicans) and Aspergillus 
fumigatus (A.  fumigatus) appear to be ideal model pathogens 
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for consistently activating NETosis via NADPH oxidase, MPO, 
and NE, thus using a mechanism similar to PMA (9, 10, 35, 
126–129). However, there is no evidence that citrullination or 
pathways activated by calcium ionophores are required by these 
fungi to induce NETosis.
The mechanisms of bacterial induction of NETs, however, 
are inconsistent. S. aureus has been used as a model organism to 
demonstrate bacterial NET formation by both NADPH oxidase-
dependent (PMA-like) and NADPH oxidase-independent path-
ways (5, 81). S. aureus has also been reported to induce “vital” 
NET formation, a morphological description chosen to highlight 
that neutrophils remain “alive” (i.e., transiently functional and 
somewhat motile) after releasing NET-like structures (130, 131). 
Other bacterial species face similar caveats. For example, Klebsiella 
pneumoniae has been shown to require MPO and NE to induce 
NETosis in mice (PMA-like?) (10). However, the induction of 
NETs by K. pneumoniae in vitro was not reproducible (128). In 
the case of Shigella flexneri (S. flexneri) and group A Streptococcus 
pyogenes (S. pyogenes) deficient in an extracellular DNase (Sda1), 
used to support that PAD4 is required to induce NETs (37), the 
mechanism(s) that may drive PAD4 activation remain elusive. 
Indeed, it has been proposed that only large pathogens such as 
C. albicans hyphae and bacterial aggregates have the capacity to 
induce NETosis, questioning experiments that involve the induc-
tion of NETosis by single-cell suspensions of bacteria that are not 
aggregated (128).
The poor reproducibility of NET formation by some bio-
logically relevant stimuli and the limited understanding of these 
discrepancies may explain why PMA and calcium ionophores 
remain primary tools in the study of NETs.
Synergistic Signals May Be Required to Efficiently 
Trigger NADPH Oxidase-Dependent NETosis
Several stimuli that were initially proposed to induce NETs 
are poor activators of NADPH oxidase (such as IL-8, LPS, and 
TNF-α) (119–123, 125). However, it is fascinating that these mol-
ecules can prime neutrophils to produce high amounts of ROS 
in response to a second signal, such as fMLP (119, 120, 125), a 
peptide that mimics bacterially derived signals by activating the 
formyl peptide receptor 1 (FPR1) (132). Similarly, neutrophil 
priming with interleukin-1β (IL-1β), TNF-α, granulocyte mac-
rophage colony-stimulating factor (GM-CSF), and granulocyte 
colony-stimulating factor (G-CSF) enhances ROS production by 
IL-8 (121, 123). Although the ability of LPS itself to induce NETs 
is uncertain, the combination of platelets and LPS induces platelet 
aggregation and acts as a potent stimulus for NETosis (124). 
Therefore, it is conceivable that NETs are induced under syner-
gistic circumstances where more than one inflammatory and/or 
bacterial stimulus may be present (e.g., infection), although these 
stimuli in isolation may not induce NETosis.
NET-Like Structures Induced by Calcium Ionophores 
Mimic Damage to the Cellular Membrane
Stimuli that induce NETs through physiological pathways 
mimicking the action of calcium ionophores are more difficult 
to elucidate. PADs are calcium-dependent enzymes that require 
millimolar amounts of calcium for in vitro activity (38). In cells, 
however, PAD activation can be observed during biological 
processes (73) and in response to physiologic stimuli (51, 93, 94, 
133) that do not increase intracellular calcium concentrations 
above the nanomolar range. Activation of PADs has therefore 
been posited to require cellular cofactors that modulate calcium 
sensitivity of the enzyme. Nonetheless, citrullination under 
these conditions represents a tightly controlled process. Protein 
citrullination appears limited to nuclear substrates involved 
in gene regulation such as histones and transcription factors, 
with no damage to the cell (51, 73, 93, 94, 133). In contrast, 
calcium ionophores induce hypercitrullination of proteins 
across multiple cellular compartments, including many likely 
“accidental” targets. These fundamental differences between 
limited protein citrullination induced by physiologic stimuli 
and hypercitrullination observed with calcium ionophores 
may be best explained by the kinetics and absolute amount 
of calcium influx.
Calcium ionophores induce rapid, prominent, and sustained 
increases in cytosolic calcium concentration in neutrophils (above 
1 μM) (110, 111). In contrast, even the most potent physiologic 
stimuli only induce transient increases in cytosolic calcium below 
1 μM. fMLP, likely one of the most potent activators of intracel-
lular calcium signaling, increases cytosolic calcium to a transient 
peak of 500–800 nM that returns to baseline within 2–3 min (111, 
134, 135). Other stimuli, such as IL-8 and C5a, generate similar 
transient increases in cytosolic calcium, but with much smaller 
effect sizes (~300–400 nM) (110, 123). Under these conditions, 
it is hard to envision that PAD4 could be hyperactivated by 
these stimuli. Indeed, fMLP, IL-8, and other stimuli that induce 
transient cytosolic calcium increases are unable to reproduce 
calcium ionophore-induced hypercitrullination (58). Moreover, 
fMLP fails to induce NETs (27), reinforcing that limited eleva-
tions in intracellular calcium are insufficient to generate NET-
like structures. In contrast to calcium ionophores, which lead 
to decreased chemotaxis (likely because the cells disintegrate) 
(113, 136), intracellular calcium signals activated by fMLP, IL-8, 
C5a, and interferon (IFN)-γ are potent chemotactic factors (122, 
137–139). This again highlights major physiological differences 
between signals that slightly increase cytosolic calcium and the 
effect of calcium ionophores.
Considering that no physiological stimulus is known to 
reproduce the effects of calcium ionophores on neutrophils, we 
propose that ROS production via NADPH oxidase is the pri-
mary mechanism for NETosis. In contrast, NET-like structures 
induced by calcium ionophores (a form of cell death distinct 
from NETosis) may be representative of pathological conditions 
that drive massive intracellular calcium influx and hypercitrul-
lination as result of direct damage to the cellular membrane. To 
distinguish this form of neutrophil death from NETosis, we will 
use the term leukotoxic hypercitrullination.
Bacterial and immune pore-Forming 
proteins induce neutrophil death by 
Leukotoxic Hypercitrullination
Several unique features distinguish LTH from NETosis, which 
are as follows: (1) the NET-like structures are triggered by 
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prominent and sustained calcium influx and can be inhibited 
by chelation of extracellular calcium (66), (2) are generated 
independently of NADPH oxidase activity (66), (3) require 
PAD4 activity and are suppressed by PAD inhibitors (14, 36), (4) 
undergo rapid formation (within minutes) (36), and (5) protein 
citrullination is not limited to histones and transcription fac-
tors, but encompassing proteins across all molecular weights 
(54). Whether cellular membrane rupture is required for the 
release of nuclear content into the extracellular space during 
LTH is not known.
S. aureus, Staphylococcal Pore-Forming Toxins, 
and Leukotoxic Hypercitrullination during Bacterial 
Infection
The idea that NET-like structures induced by calcium ionophores 
are representative of membranolytic pathways is derived from 
the studies of S. aureus, which induces NETs through a variety of 
mechanisms (5, 81, 130). To induce bactericidal (true) NETosis, 
S. aureus requires growth under conditions that preclude the 
expression of bacterial toxins (5). In contrast, when neutrophils 
are exposed to toxin-producing strains of S. aureus, rapid and 
NADPH oxidase-independent formation of NET-like structures 
was observed (81). Strikingly, the study also identified that this 
unique form of “NETosis” (we argue this actually represents 
LTH) was triggered by Panton–Valentine leucocidin (PVL), a 
pore-forming toxin secreted by highly virulent S. aureus strains 
that induces a rapid, prominent, and sustained increase in 
intracellular calcium (140, 141). Since phagocytosis is a potent 
stimulus to activate NADPH oxidase (142), it is likely that, by 
avoiding the action of pore-forming toxins, the engulfment of 
S. aureus by neutrophils in the initial studies by Fuchs and col-
leagues allowed for ROS production and NETosis (5). However, 
LTH (toxin-induced neutrophil death without phagocytosis) 
is likely to predominate during human bacterial infection. 
This mirrors the initial morphological observations of dying 
neutrophils during human skin infection by Metchnikoff (1). 
Interestingly, different to NETosis that requires rupture of the 
cellular membrane to release DNA and NETs, NET formation 
induced by PVL appears to release chromatin via nuclear enve-
lope blebbing and vesicular exportation, preserving the integrity 
of the cell membrane (81). In fact, “vital NETosis” described in 
mice infected with S. aureus may represent LTH induced by PVL 
or other staphylococcal pore-forming toxins (130, 131). In addi-
tion to PVL, S. aureus produces several other membranolytic 
toxins that can induce rapid formation of NET-like structures 
(143, 144). These proteins include N-terminal ArgD peptides 
and leukotoxin GH (LukGH), possibly among others that have 
not been studied in detail.
Finally, two additional features are important to support that 
membrane pore formation, calcium influx, and hypercitrullina-
tion are involved in the process of chromatin extrusion induced 
by S. aureus. First, it has been demonstrated that PAD4 inhibitors 
decrease the production of “NETs” by S. aureus (14). Second, we 
demonstrate here that PVL is a potent inducer of cellular hyper-
citrullination in human neutrophils (Figure 2B), which contrast 
with the absence of citrullination in neutrophils activated with 
PMA (Figure  2A). Thus, LTH, but not NETosis, is likely the 
mechanism underlying NADPH oxidase-independent “NET” 
formation observed with S. aureus.
Bacterial Pore-Forming Toxins as Triggers of 
Leukotoxic Hypercitrullination – The Need for 
Standards in the Definition and Study of NETs
The model that bacterial pore-forming proteins are responsible 
for inducing LTH and secondary extrusion of nuclear material is 
not limited to S. aureus. Pore-forming toxins are potent virulence 
factors produced by many pathogenic bacteria carrying diverse 
cellular specificities (145–147). These protein toxins have the 
ability to change from a water-soluble state to a membrane-bound 
and membrane-inserted conformation. This large family of mol-
ecules includes both short peptides and large globular proteins 
and is expressed both by Gram-positive and Gram-negative 
bacterial species alike (145–147).
For the context of this review, the primary and unifying effect 
of bacterial pore-forming toxins is the ability to induce rapid 
changes in ion concentration in the cytosol of their respective 
target cells, specifically an increase in intracellular calcium (145, 
148). Early studies on the mechanisms of cell damage by bacte-
rial pore-forming toxins indeed suggested that these molecules 
act as calcium ionophores (149). The capacity of toxins secreted 
by bacteria to induce NET-like structures is not novel and 
has previously gained the attention of others (150). However, 
the potential link between bacterial pore formation, calcium 
influx, and hypercitrullination has not been considered as a 
driver of cellular damage and DNA extrusion. The production 
of pore-forming toxins therefore is a critical variable that must 
be considered to interpret mechanisms of NET formation used 
by pathogenic bacteria. It is thus important to communicate 
whether bacteria were cultured under conditions that allow for 
toxin production, whether the specific strains used produce or 
are deficient of toxins, the spectrum of toxin expression, and 
their concentration. Finally, future studies on NETosis should be 
required to disclose whether bacteria were opsonized to facilitate 
phagocytosis, as this may alter their ability to generate ROS and 
thus induce NETosis.
Inhibition of PAD4 Activity in NETosis and Leukotoxic 
Hypercitrullination
The use of PAD4-deficient mice and PAD4 inhibitors to block 
NET formation is frequently presented as evidence that citrul-
lination is required for the induction of NETosis (14, 37). It is 
important to appreciate, however, that these studies employed 
conditions that promote PAD activation and DNA extrusion 
by calcium influx, not through stimuli that induce NETosis. 
In the case of PAD4 inhibitors (14), ionomycin and S. aureus, 
both inducers of calcium-dependent and NADPH oxidase-
independent pathways, were used to demonstrate that PAD4 
inhibition can block histone H3 citrullination and possibly the 
formation of “NETs” (albeit incorrectly quantified by histone 
H3 citrullination, not chromatin extrusion). The inhibition of 
“NETs” in a murine model of sepsis can be similarly explained 
by blocking LTH rather than NETosis (151).
In mice deficient in PAD4, S. flexneri and S. pyogenes were 
used to address the role of PAD4 activity during NETosis (37). 
BControl Perforin
10 mm 10 mm
FigUre 3 | purified perforin induces pad activation and the release of extracellular dna in neutrophils. Human neutrophils (5 × 105 cells/50 μL) in 
HBSS/10 mM Hepes/1.5 mM CaCl2 were plated onto standard microscope slides coated with poly-d-lysine (Sigma) and incubated for 30 min at 37°C to allow for 
cell attachment. Neutrophils were then incubated in the absence or presence of sublytic amounts (500 ng/mL) of purified perforin (Enzo Life Science) for 1 h at 
37°C, as previously described (58). Then, the cells were fixed, permeabilized, and stained with anti-histone H3 (citrulline 2 + 8 + 17) antibodies (H3cit) and Alexa 
Fluor 594 goat anti-rabbit F(ab′)2 fragment (Invitrogen, Cat# A-11072). Cells were mounted with ProLong Gold (Molecular Probes) plus DAPI. Samples were 
analyzed using a Zeiss axioscope microscope. Excitation filter: 510–560 nm for Alexa Fluor 594 and excitation filter: 300–390 nm for DAPI. Merged images of DAPI 
(blue) and H3cit (red) staining are shown. Perforin induces PAD activation (detected by citrullination of histone H3) and the extracellular release of neutrophil DNA 
(arrowheads). The experiments were performed on at least four separated occasions, with similar results.
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Interestingly, both bacteria produce virulence factors that can 
affect calcium homeostasis. Shigella has been shown to induce 
calcium responses that are dependent on the type III secretory 
apparatus. This allows for the insertion of a pore containing the 
IpaB and IpaC proteins into host cell membranes and acts in 
conjunction with the pore-forming toxin hemolysin E (HlyE) 
(152–154). S. pyogenes streptolysin O (SLO), a cholesterol-
dependent cytolysin (CDC), forms large transmembrane pores 
evolutionary related to immune pore-forming proteins that 
permit extracellular calcium flux into the target cell cytosol 
(147, 155).
While the abnormal activation of PAD4 induced by ionomycin 
or bacterial toxins can easily explain the effect of PAD4 inhibitors 
and PAD4 deficiency in these studies, it remains uncertain how 
these inhibitors could block PMA-induced NETosis (18), which 
proceeds without PAD4 activation (32, 71). It is conceivable that 
molecules designed to block PADs exert additional functions 
that indirectly affect PMA-induced NETosis. We also cannot 
exclude that some residual activity of PAD4 is maintained in the 
presence of PMA, resulting in limited citrullination of histones 
that may contribute to chromatin decondensation, without 
affecting their antimicrobial properties (as discussed below). 
Indeed, trace citrullination of histone H3 has been reported 
in neutrophils in response to LPS and other stimuli (71, 156). 
However, some of these stimuli are highly unreliable means to 
induce NETosis (27, 124).
Since the expression of pore-forming toxins easily confounds 
the study of NETosis induced by bacterial species, the fungi 
C. albicans and A. fumigatus may represent a better model to 
interrogate the effect of PAD4 deficiency and inhibition in the 
induction of NETs.
Immune Pore-Forming Proteins – A Role 
for Complement and Perforin in Leukotoxic 
Hypercitrullination?
Pore-forming proteins are not exclusive to microbial species. 
Vertebrates have evolved similar systems to kill infectious agents 
[i.e., the complement membrane attack complex (MAC)], as 
well as infected or malignant cells (i.e., perforin) (157). Similar 
to other proteins that create transmembrane pores, MAC and 
perforin promote prominent calcium influx, PAD activation, 
and cellular hypercitrullination (58). Moreover, we found that 
perforin also induces the extracellular release of DNA (Figure 3), 
which may erroneously be attributed to NETosis in the future. We 
anticipate that killing of neutrophils by complement MAC would 
have a similar effect.
We believe that these data are consistent with the herein 
proposed model that calcium ionophores act analogous to pore-
forming proteins, which drive cellular damage, hypercitrullina-
tion, and chromatin extrusion mimicking NETosis (i.e., LTH). 
Defining the independent role of toxins secreted by each patho-
gen shown to induce “NETosis” would be necessary to confirm or 
discard this hypothesis.
Does PAD2 Play a Role in Leukotoxic 
Hypercitrullination Induced by Pore-Forming Proteins?
PAD2 is an abundant enzyme in neutrophils and is potently 
activated in cells using calcium ionophores or perforin. 
Hypercitrullination induced by PAD2 generates a repertoire 
of citrullinated proteins that is even more prominent than the 
pattern observed with PAD4 (54, 58), with protein targets that 
are common and unique for both enzymes (50). Proteins of the 
cellular cytoskeleton, such as actin and vimentin, are prominently 
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citrullinated by PAD2 (50, 54). This may contribute to the 
dismantling of neutrophils during cellular hypercitrullination. 
Whether hyperactivation of PAD2 plays any direct role in this 
process, as demonstrated for PAD4 (65), is unknown. Elucidating 
a potential role of PAD2 during LTH is of great interest as targeted 
inhibition of PAD4 will likely have negligible effects on PAD2 
hyperactivation and its consequences.
netosis and Leukotoxic 
Hypercitrullination in immunity: 
protein Citrullination May impair the 
Bactericidal Function of nets
Based on our proposed model, neutrophils can suffer two 
biochemically distinct forms of cell death that can easily be 
confused morphologically. One is driven by signals that induce 
ROS production by NADPH oxidase (NETosis), the other 
involves bacterial toxins that generate transmembrane pores, 
abnormal calcium influx, neutrophil hypercitrullination, and the 
extracellular release of chromatin (LTH). Applying this model, 
what would be the biological significance of these distinct forms 
of neutrophil death?
In 1942, Miller and colleagues identified that histones have 
potent antimicrobial activity (158). It was later demonstrated 
that the arginine-rich histone fraction can effectively kill both 
Gram-positive and Gram-negative bacteria at nanomolar con-
centrations (159). More recently, the importance of histones as 
potent bactericidal factors was resurrected by the discovery that 
the antibacterial activity in NETs is largely dependent on histones 
(2). The mechanism by which histones kill bacteria is not fully 
understood, but has been attributed to their high content of 
arginine and lysine. These cationic residues are thought to allow 
for binding, disruption of the bacterial membrane, and transloca-
tion of small antibacterial molecules (160). Using histone-derived 
antimicrobial peptides, it was shown that arginine is required 
for antimicrobial activity, membrane embedding, and peptide 
translocation (160). Since histones are potent antimicrobial fac-
tors in NETs and their arginine content is critical for bactericidal 
function, it is not surprising that decreasing the number of argi-
nine residues during histones citrullination reduces their potent 
antimicrobial activity (37). Similarly, citrullination of the cationic 
bactericidal protein LL37 attenuates its capacity to neutralize LPS 
and to protect against endotoxin-induced death in mice (161).
From an evolutionary perspective, we believe that the 
inactivation of PAD4 that occurs during NETosis is unlikely to 
be accidental (71). This inhibition may have evolved to avoid 
citrullination-mediated inactivation of critical antimicrobial 
factors (e.g., arginine-rich bactericidal proteins) released during 
NETosis. Although the spectrum of citrullinated proteins induced 
by bacterial toxins in neutrophils has not been described to date, 
antimicrobial proteins including MPO, NE, azurocidin, and 
defensins appear to be targets of citrullination induced by iono-
mycin (63). This suggests that antimicrobial components of NETs 
other than histones may be similarly inactivated by citrullination.
NETosis and toxin-mediated LTH may represent two funda-
mentally opposed strategies used by the innate immune system 
and microbial pathogens to kill each other (Figure 4). NETosis 
defines a form of programed, antimicrobial cell death initiated by 
signaling pathways that suppress PAD activation and induce the 
release of bactericidal NETs. This process is dependent on ROS 
production via NADPH oxidase. Stimuli that generate NETosis 
may include inflammatory cytokines acting synergistically, bac-
terial products, fungi, and opsonized bacteria that can potently 
activate NADPH oxidase. In contrast, pathogens have evolved 
strategies that generate abnormal and sustained increases in cyto-
solic calcium of target cells through pore-forming toxins. This 
process hyperactivates calcium-dependent pathways (PADs), 
thus rapidly inactivating antimicrobial neutrophil factors and 
triggering disintegration of the target cell.
The deleterious effect of hyperactivation of PAD4 and LTH 
on the antimicrobial function of neutrophils is further supported 
by several findings, which are as follows: (1) NET-like structures 
induced by toxin-expressing strains of S. aureus have limited 
proteolytic activity; this loss of function is PVL-dependent (81), 
(2) NET-like structures induced by the S. aureus pore-forming 
toxin LukGH demonstrate no antimicrobial potential against this 
bacterium (144), in striking contrast to the potent bactericidal 
activity of PMA-induced NETs (2), (3) Group B Streptococcus 
induces neutrophil lysis, NET-like structures and resistance to 
NET-mediated bacterial killing via its hemolytic pigment/lipid 
toxin (162), (4) PAD4-deficient mice are partially protected from 
LPS-induced shock and demonstrate increased production of 
IL-10 (163), and (5) PAD inhibition increases survival in a murine 
model of sepsis (151), supporting that PAD4 activity negatively 
affects the host during infection.
Leukotoxic Hypercitrullination vs. netosis 
in rheumatoid arthritis pathogenesis
The induction of LTH by pore-forming proteins may not only 
be detrimental for the clearance of pathogens. The hypercitrul-
lination of self-proteins that are not physiological targets of 
PADs may have a primary role in generating neoantigens. This 
cellular dysregulation may have important implications for the 
etiology and pathogenesis of RA, as citrullinated proteins are 
major targets of the autoimmune response in this disease (17). 
Immune-mediated membranolytic pathways (perforin and MAC 
formation) are activated in the rheumatoid joint and may drive 
the generation of citrullinated autoantigens in established disease 
(58). Similarly, chronic hypercitrullination induced by bacterial 
pore-forming toxins may represent a primary source of citrul-
linated autoantigens in susceptible individuals with the potential 
to initiate the ACPA response and RA.
The hypothesis that NETosis is the source of citrullinated 
autoantigens in RA, as proposed in recent years, contradicts 
experimental data showing that hypercitrullination does not occur 
during NETosis (58, 71). This contradiction may be explained by 
the following points. (1) Studies on RA pathogenesis frequently 
use calcium ionophores to induce citrullination in neutrophils, 
which mimic LTH induced by pore-forming pathways, but not 
NETosis (63, 164). It is likely that the arbitrary use of PMA and 
calcium ionophores may be a major confounder in the study of 
autoantigen citrullination in RA. (2) Neutrophils dying by LTH 
in the RA joint cannot be morphologically distinguished from 
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FigUre 4 | theoretical models of biological mechanisms of dna release in neutrophils. The three models are depicted and illustrate their potential triggers, 
biochemical pathways, and biological consequences. (a) NETosis is initiated by stimuli that potently activate NADPH oxidase and ROS production, but decreases 
PAD4 activation and likely mtROS production. NETosis is antimicrobial, potentially anti-inflammatory, and has limited protein citrullination. (B) Leukotoxic 
hypercitrullination is triggered by stimuli that generate prominent and sustained increases in cytosolic calcium, such as ionophores and proteins that damage the 
cellular membrane (e.g., pore-forming proteins). PAD hyperactivation and protein hypercitrullination are characteristic of this process, but not ROS production by 
NADPH oxidase. While mtROS may have some role in the release of DNA by calcium ionophores in neutrophils (32), the relevance of this pathway in neutrophil 
damage induced by pore-forming proteins is unknown. Antimicrobial functions and the immunogenicity of self-antigens are affected as a result of cellular 
hypercitrullination. (C,d) To compensate a constitutive defect in mitophagy, neutrophils normally extrude mitochondrial components, including mtDNA, as a 
mechanism for mitochondria clearance. (C) The process of mtDNA expulsion (MDEX) may be enhanced by inflammatory signals such LPS or C5a following 
neutrophil priming with GM-CSF and requires NADPH oxidase activity. (d) IFN-I and RNP-ICs alter the normal disposal of mitochondria in neutrophils and promote 
the expulsion of ox-mtDNA (OMEX). This process is dependent on mtROS, but not NADPH oxidase, and may be predisposed by factors that decrease NADPH 
oxidase activity. Different to mtDNA, ox-mtDNA is pro-inflammatory and highly interferogenic. LDGs from patients with SLE have spontaneous OMEX. The role of 
citrullination in (C,d) is unknown. The question marks (?) reflect pathways/functions that require further experimental confirmation.
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NETosis. This may falsely suggest that NETosis is increased in 
RA and relevant to disease pathogenesis. (3) Citrullination in the 
cellular compartment of the rheumatoid joint is characterized by 
modification of a broad range of proteins and autoantigens (58, 
165, 166) and can only be reproduced in vitro by membranolytic 
damage to the neutrophil (58). In contrast, in vitro studies that 
aimed to define a role of NETosis in autoantigen citrullination are 
less stringent and posit that citrullination of one or two proteins 
is sufficient evidence to link NETosis and RA. (4) The potential 
success of PAD4 deficiency and PAD inhibitors in treating 
experimental arthritis may be misinterpreted as in vivo evidence 
that NETosis is relevant for RA, while this effect may result from 
transcriptional repression of immune effector functions or inhi-
bition of LTH.
It is the opinion of these authors that the role of NETosis in 
autoantigen citrullination needs to be revisited. This reappraisal 
needs to consider the type of stimulus used, the spectrum of cit-
rullinated autoantigens generated during NETosis, and whether 
this spectrum is representative of the citrullinome in the RA 
joint (58, 165, 166). It further requires the presence of appropri-
ate negative controls to confirm the specificity of citrullinated 
protein detection.
Depending on the mechanism that inactivates PAD4 during 
NETosis (reversible vs. irreversible) (71), it is possible to assume 
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that PADs released during this process may promote citrullina-
tion of extracellular substrates (167). Nevertheless, neutrophils 
dying by necrosis or LTH are even more efficient than NETosis to 
induce citrullination of extracellular substrates (167), suggesting 
that NETosis itself may not be required for this process.
other Forms of Cell death that  
May Mimic netosis
Defective Mitophagy in Neutrophils
Since mitochondrial dysfunction can have deleterious effects 
on cells, quality control mechanisms have evolved to eliminate 
damaged mitochondria (168). However, while most cells use an 
autophagic process called mitophagy to remove damaged mito-
chondria, recent evidence demonstrated that mitophagy is defec-
tive in neutrophils (19). To compensate this problem, neutrophils 
employ two complementary pathways to achieve mitochondrial 
clearance. (1) Mitochondrial contents including mtDNA in 
complex with transcription factor A mitochondria (TFAM) are 
expelled from the neutrophil. This likely happens through direct 
fusion of the mitochondria with the plasma membrane. The 
release of mtDNA–protein complexes into the extracellular space 
is therefore a normal process in neutrophil biology. (2) If mtDNA 
undergoes oxidation, it dissociates from TFAM and is redirected 
to lysosomes for degradation (19).
Interestingly, early studies had demonstrated that expulsion of 
mtDNA from neutrophils can be induced by LPS or complement 
C5a following priming with GM-CSF (7) (Figure 4). This may 
indicate physiologically increased clearance of mitochondria 
in response to inflammatory stimuli. Due to morphological 
similarities with NETosis (extracellular DNA), however, these 
structures have been termed mitochondrial NETs. Different to 
actual NETs, mtDNA is released from viable neutrophils and does 
not appear to contain histones, neutrophil granule proteins (e.g., 
MPO and PR3), or antimicrobial properties (7). The analogy with 
NETs is therefore unsuitable and creates confusion around the 
biology of NETosis. Importantly, no rationale exists to posit that 
citrullination may have a role in the release of mtDNA–protein 
complexes from neutrophils, reinforcing that PAD4 is not central 
to any process that releases DNA and so-called NETs.
Neutrophil Extracellular ox-mtDNA in SLE
In 2011, three different groups suggested distinct mechanisms to 
explain a possible increase of NETosis in patients with SLE (83, 
169, 170). While no effort was made by other groups to support 
or discard any of these models, two recent studies stressed that 
NETosis may indeed play no role in SLE pathogenesis (19, 100). 
Instead, the release of ox-mtDNA from neutrophils, initially 
mistaken for NETosis, appears to be relevant to SLE (19). While 
data from either study can lead to similar conclusions, some dif-
ferences deserve attention.
In previous studies, freshly isolated neutrophils from patients 
with SLE were shown to suffer NETosis when exposed to 
ribonucleoprotein-containing immune complexes (RNP-ICs) via 
TLR7 and FcγRIIa ligation. This unique process was reproduced 
in neutrophils from healthy controls when cells were primed 
with type I IFN (IFN-I) to induce TLR7 expression (170). Using 
a similar model, Caielli and colleagues challenged this paradigm 
and demonstrated that defective mitophagy together with IFN 
priming, but not NETosis, is responsible for the release of pro-
inflammatory ox-mtDNA in response to RNP-ICs (19). In this 
scenario, neutrophil exposure to IFN-I and RNP-ICs interferes 
with the disassembly of mtDNA–TFAM complexes, which are 
required for ox-mtDNA disposal by lysosomes. This results in 
ox-mtDNA accumulation in mitochondria and further expul-
sion as highly interferogenic ox-mtDNA–TFAM complexes (19). 
Different to NETosis, neutrophils remain alive while releasing 
ox-mtDNA in the extracellular space, gDNA is not released, and 
the process is dependent on mtROS, but not NADPH oxidase 
(19) (Figure  4). While Lood and colleagues reached similar 
conclusions in regard to the release of ox-mtDNA in response 
to RNP-ICs and the requirement of mtROS, but not NADPH 
oxidase, they found that IFN-I priming was not required to drive 
this process (100). They also described that a similar process 
spontaneously occurs in low-density granulocytes (LDGs), a 
subset of inflammatory granulocytes enriched in SLE (100).
While the studies by Caielli and Lood were performed using 
distinct populations of patients (pediatric vs. adult) (19, 100), it 
is unclear whether this may explain the difference in the require-
ment of type I IFN to induce TLR7, as RNP-ICs signal through 
this receptor (170).
Although the study by Lood and colleagues still uses the term 
NETosis (100), both studies are consistent with the evolving idea 
that this form of neutrophil death is not involved in the patho-
genesis of SLE. Instead, mechanisms that enhance the produc-
tion and release of ox-mtDNA may be responsible for generating 
critical inflammatory components that contribute to SLE patho-
genesis. Importantly, these studies support the conclusions by 
Campbell and colleagues in lupus-prone mice deficient in Nox2 
(the p91phox component of the phagocyte NADPH oxidase), 
which demonstrated that NETosis does not contribute to lupus 
in vivo. Since Nox2 deficiency exacerbates lupus in these mice, 
NETosis, or some other activity linked to Nox2, instead acts to 
inhibit disease pathogenesis (99). This fascinating idea is fur-
ther supported by the observation that deficiencies in NADPH 
oxidase activity in humans are associated with SLE, lupus-like 
disease, lupus autoantibodies, and a systemic IFN-I signature 
(100, 171–175). Neutrophils from these patients are resistant 
to NETosis, but have fully conserved mtROS activity (176), 
which together may predispose to SLE. Finally, individuals with 
NADPH oxidase deficiency have an increased risk of fungal and 
bacterial infections (176), underscoring that the sole expulsion 
of mtDNA or ox-mtDNA is not antimicrobial and should not 
be considered a form of NETosis. As NADPH oxidase appears 
to be protective for the development of SLE, it is possible that 
this enzyme complex regulates the production or clearance 
of neutrophil ox-mtDNA. Indeed, strong evidence supports 
an interplay between mitochondria and NADPH oxidase that 
may provide both feed-forward and feedback regulations in the 
production of ROS (177). Moreover, it is interesting to highlight 
that the extracellular release of mtDNA induced by GM-CSF 
and LPS/C5a is dependent on NADPH oxidase (7), support-
ing that this enzyme complex has a role in the maintenance of 
mitochondria in neutrophils. NETosis could moreover be pro-
tective for SLE by degrading cytokines and chemokines (178). 
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The finding that the inhibition of NETosis by PTU induces the 
production of anti-MPO antibodies and vasculitis in rats (98) 
further supports a protective role of NETosis in autoimmun-
ity. Defining the role of NADPH oxidase in SLE has therefore 
implications for both disease pathogenesis and the development 
of therapeutic strategies.
ConCLUding reMarKs
The biochemical and functional distinction of NETosis, LTH, 
and defective mitophagy is critical to understanding the distinct 
role of these processes for human immunity and autoimmunity. 
While the extracellular release of neutrophil DNA induced by 
various stimuli may appear morphologically similar, they seem 
to be consequences of opposing evolutionary forces. Here, we 
propose the existence of at least three distinct mechanisms that 
drive the active extrusion of neutrophil DNA (Figure 4), which 
are as follows: (1) NETosis, which represents a hardwired cellular 
program that likely evolved to kill pathogens, (2) LTH, which is 
the cellular consequence of successful strategies that evolved in 
specific pathogens to kill neutrophils (membranolysis), and (3) 
the expulsion of mtDNA, which represents a normal function in 
neutrophil biology to clear the cell of damaged mitochondrial 
material, but can generate ox-mtDNA in the SLE environment. 
While these processes can be easily studied by defining the 
effects of PMA, calcium ionophores and IFN-I plus RNP-ICs 
on neutrophils, it is important to emphasize that these stimuli 
are artificial. They are most likely non-representative of the 
complexity of signals that converge in the neutrophil during 
infection or autoimmunity. We anticipate that variations of these 
mechanisms exist in vivo.
The attempt to derive a biochemical definition of the distinct 
processes that release DNA from neutrophils offers a unique 
opportunity to reevaluate the role of PAD4 and NETosis as drivers 
and potential targets in human diseases. Based on this model, the 
use of PAD inhibitors may be indicated to block the detrimental 
effects of LTH, but not NETosis. First, PAD inhibitors could act 
as “antibiotics” to prevent ongoing hypercitrullination induced 
by bacterial toxins, thus allowing bactericidal NETosis to occur. 
The finding that the PAD inhibitor Cl-amidine improves survival 
in a murine model of sepsis strongly supports this hypothesis 
(151). Second, they may decrease the burden of citrullinated 
autoantigens in RA without affecting NETosis, which has been 
shown to have distinct anti-inflammatory activities (178). Given 
that ionomycin and perforin induce hyperactivation of PAD2 and 
PAD4 in neutrophils, it is conceivable that blocking LTH may 
require inhibition of both enzymes. Third, PAD4 inhibitors may 
have an indication to treat autoimmune diseases as transcrip-
tional repressors of immune effector functions, but not under the 
rationale that these molecules act by blocking NETosis. In SLE, 
the use of PAD4 inhibitors to block the production and release of 
ox-mtDNA has no rationale, unless it is demonstrated that this 
enzyme is essential for this process. Blocking the production of 
mtROS, however, may be reasonable.
Besides infectious and autoimmune diseases (e.g., SLE) that 
have been associated with decreased production of NETosis (as 
consequence of NADPH oxidase deficiency) (100, 171–176), 
diseases related to an increased neutrophil propensity to undergo 
NETosis need to be carefully defined. A better biochemical 
definition of the diverse mechanisms that can affect neutrophil 
function should allow for the identification of novel biomarkers 
and help with the classification of disease entities that may benefit 
from targeting those pathways. There remains a need to clarify 
the true role of NETosis in human health and disease.
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